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Abstract
Background: The emergence of ß-lactamase- producing Klebsiella 
pneumonia, represents a significant diagnostic and therapeutic 
challenge to the management of infections caused by this organism. 
This prospective study aimed to study the frequency of ß-lactamase 
production by K. pneumoniae in neonatal intensive care unit (NICU) 
of Mansoura University Children’s Hospital in Egypt. 
Methods: This study was conducted over a period of 36  months from 
September 2010 to August 2013, where 684 samples were collected 
from different body sites of neonates in the NICU. Microbial isolation, 
identification and antimicrobial susceptibility testing were carried out. 
ß-lactamase production by K. pneumoniae isolates was confirmed by 
phenotypic methods and PCR amplification of related genes using a six-
gene panel for the amplification of the blaCMY-2, blaDHA, blaACC, blaSHV, 
blaTEM and blaCTX-M genes. In vitro transformation and conjugation 
were carried out to detect plasmid mediated AmpC ß- lactamase 
resistance by transmission to E. coli. 
Results: K. pneumoniae was isolated at a rate of 12.6% and ß-lactamase 
production was detected in 62.8% of the isolates.  The most commonly 
detected ß-lactamase gene was blaSHV (51.9%), followed by BlaCMY-2 
(16.7%), blaDHA (13%), blaTEM (9.2%), blaCTX-M (7.4%) and blaACC (1.9%). 
Additionally, some strains carried combinations of two or three genes. 
The plasmid carrying blaCMY-2 was 100% successfully transformed 
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Introduction
Beta-lactamase producing K. pneumoniae 
has been increasingly noticed as a problematic 
pathogen in different hospital settings. Moreover, 
the widespread and misuse of antibiotics, continues 
to increase resistance in Beta-lactamase drugs and 
to reduce the chance for cure and hamper infection 
control measures in hospitals worldwide (1,2).
Beta-lactamases are a group of enzymes that 
inhibit ß- lactam drugs by breaking their active 
ring structure. The most important ß-lactamases 
are those produced by Enterobactericae. These 
enzymes are mostly responsible for therapeutic 
failure to this crucial group of drugs (3). 
Two types of Ampler class A ß-lactamases are 
known to inhibit third generation cephalosporins, 
and these spread rapidly through chromosomal 
and plasmid mediated enzymes in Gram-negative 
bacteria. The plasmid mediated process is more 
critical being transferable among different species of 
Enterobactericae. Extended spectrum ß-lactamases 
(ESBLs) resist all ß-lactams, except cephamycin 
and carpabenems and include a classical type that 
is a mutant of TEM and SHV and especially the 
CTX-M type (4). Moreover, Ampler class C (AmpC) 
β-lactamases are clinically important, since these 
mediate resistance to broad range cephalosporins 
including cephamycins and being resistant to 
clavulanates (5). Chromosomal AmpC enzymes are 
inducible and non-transferable. The transferable 
plasmid mediated AmpC genes favored their 
dissemination among Enterobacteriaceae. Plasmid-
encoded blaCMY, blaDHA, and blaACC determinants 
producing class C enzymes are described with 
increasing frequencies (6).
This work aimed to investigate the prevalence of 
K. pneumoniae as a nosocomial pathogen and its 
molecular resistance determinants in the NICU of 
Mansoura University Children’s Hospital.
Patients and Materials
Study population 
This prospective study included neonates 
suspected of having nosocomial infection (NI) after 
48 hours of admission to the NICU. A thorough 
history, clinical monitoring and laboratory tests 
were performed and documented on standard 
forms .Clinical sepsis evaluation was performed and 
divided into five categories as described by Grether 
into the competent E. coli LE392, while conjugation was only 77.8% 
successful using the  same E. coli strain.
Conclusion: This study demonstrates that K. pneumoniae is a common 
multidrug resistant isolate in neonatal ICU and associated with 
production of ß-lactamases  in a significant number of those isolates. 
This feature could represent a real risk for failure of therapeutic options. 
Key words: K. pneumoniae, ESBL, Egyptian neonates.
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and Nelson (7); (1) Frequent episodes of apnea and 
bradycardia; (2) seizure or change in the level of 
consciousness; (3) tachycardia, dyspnea or increase 
in respiratory support; (4) signs of septic shock; 
and (5) fever or temperature instability. Neonates 
diagnosed with early-onset sepsis were excluded. 
A case was defined as any neonate who developed 
K. pneumoniae nosocomial infection diagnosed by 
a positive culture. Parents of neonates have signed 
informed consent and the study protocol was 
approved by the ethics committee at Mansoura 
Faculty of Medicine.
Sample collection
Samples from different body sites; blood, 
urine, cerebrospinal fluid, endotracheal aspirate 
of mechanically ventilated neonates and wounds 
of surgically operated neonates were collected. 
Processing of the samples was done according 
to standard protocols used in the Microbiology 
Diagnostic and Infection Control Unit (MDICU)/ 
Department of Medical Microbiology and 
Immunology, Mansoura faculty of medicine. K. 
pneumoniae isolates were identified by colonial 
morphology, Gram-stained smears, culturing 
the isolates on MacConkey’s agar (Oxoid, UK) 
at different temperatures 4˚C, 10˚C and 42˚C to 
differentiate K. pneumoniae from other Klebsiella 
spp.(8), and using biochemical reactions (oxidase, 
catalase, gelatin liquefaction test, DNAase 
production and IMVC). Further identification to the 
species level was carried out using API 20E. Isolates 
were stored with50% sterile glycerol at -80oC.
Antimicrobial susceptibility testing
Susceptibility tests were performed using the 
Kirby–Bauer disc diffusion method and Muller-
Hinton agar (Oxoid, UK) according to the Clinical 
Laboratory Standards Institute guidelines (CLSI) (9). 
The following antibiotics were used; gentamicin 
(10µg), ceftazidime (30 µg), cefpime (30 µg), 
aztreonam (30 µg), imipenem (10µg) and ampicillin/
sulbactam (20 µg) (Oxoid, UK). 
Screening for extended spectrum 
β-Lactamases production
All K.pneumoniae isolates that showed 
resistance to any of the β-lactam drugs were tested 
for the presence of ESBL. Detection of ESBL was 
performed using double disk synergy (DDS) test on 
Mueller-Hinton agar. It was defined as an increase 
in the zone of inhibition of ≥ 5 mm with cefotaxime 
discs when they were tested in combination with 
discs containing clavulanic acid (10). The class C 
β-lactamase resistance of AmpC phenotype was 
detected by the AmpC disc test and is defined as a 
flattening or indentation of the cefoxitin inhibition 
zone in the vicinity of a sterile disc of 6 mm 
moistened with 20μl of sterile saline and inoculated 
with multiple colonies of the tested organism after 
overnight incubation at 37°C (11). A negative test 
showed undistorted zone. E. coli ATCC 25922 was 
used as a control strain.
Plasmid content and transmissibility
Plasmid DNA was extracted from the β-lactamase 
producing K. Pneumoniae isolates using the alkaline 
lysis method described by Birnhoim and Doly (1979) 
(12). E. coli LE392 strain was made competent 
using calcium chloride. Plasmid DNA (0.1-1mg in 
water) was mixed with (100ml of fresh or 200ml of 
competent cells stored at -80o C) and placed on ice 
for 30 minutes. The cells were then heat shocked 
by incubation at 42°C for 90-120 seconds and then 
back to ice for another 2 minutes (13).Conjugation 
was carried out by broth mating (at a ratio of 1:4) 
to test the transmissibility of blaCMY-2 plasmid from 
the K. pneumoniae isolates harboring this plasmid 
as donors to a recipient E. coli LE392 strain which 
was made competent using calcium chloride E. coli 
ATCC 25922 strain (14). The transformants and 
transconjugants were selected on Luria-Bertani 
agar containing ceftazidime (10 µg/ml) (Oxoid, UK).
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Characterization of the transformants and 
transconjugants 
Detection of beta-lactamase production in 
transformants and transconjugants, was confirmed 
phenotypically by the ability to grow on Luria-
Bertani agar containing ceftazidime (10 µg/ml) and 
genotypically by isolation of the blaCMY-2 plasmid, 
comparing its size with that of the donor strain. PCR 
amplification of blaCMY-2 gene was accomplished 
using primers listed in Table 1. 
PCR for β-lactamase genes
For those isolates that met the criteria for either 
the ESBL resistance or the AmpC phenotype, PCR 
was carried out using a six-gene panel for the 
amplification of the blaCMY, blaDHA, blaACC, blaSHV, 
blaTEM and blaCTX-M genes. The following thermal 
cycling program was used: 95°C for 5` followed 
by 35 x [95°C for 1`; 55°C for 1`; 72°C for1` then 
72°C for 10`. The amplified DNA fragments were 
visualized after electrophoresis of 10µl of the PCR 
samples using a 1% agarose gel (15, 16).
Results
Out of the 684 collected samples, 86 (12.6%) 
yielded positive culture results for K. pneumoniae 
isolates. These were recovered from 35 blood 
samples (40.7%), 20 wound swabs (23.3%), 
16 urine samples (18.6%) and 15 endotracheal 
aspirates (ETA) (17.44%). All isolates were sensitive 
to imipenem while none of them showed sensitivity 
to ampicillin. B-lactamases production was 
Table 1.  Specific primers used for molecular amplification of the bla genes
bla gene  Oligonucleotide sequence   Product size (bp) Reference
blaCMY2
F TGG CCA GAA CTG ACA GGC AAA
461 (15)
R TTT CTC CTG AAC GTG GCT GGC
blaDHA
F AAC TTT CAC AGG TGT GCT GGG T
405 (15)
R CCG TAC GCA TAC TGG CTT TGC
blaACC
F AAC AGC CTC AGC AGC CGG TTA T
346 (15)
R TTC GCC GCA ATC ATC CCT AGC
blaTEM
F ATA AAA TTC TTG AAG ACG AAA
867 (16)
R GAC AGT TAC CAA TGC TTA ATC A
blaSHV
F GGG TTA TTC TTA TTT GTC GC
930 (16)
R TTA GCG TTG CCA GTC CTC
blaCTX-M
F CGA TGT GCA GTA CCA GTA A
585 (17)
R TTA GTG ACC AGA ATC AGC GG
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phenotypically detected in 62/ 86 (72%) isolates as 
shown in Table 2.
The distribution of b-lactamase producing K. 
pneumoniae according to different body sites is 
shown in Table 2. The results revealed a higher 
detection among blood sample isolates; 31 (50%), 
followed by wound swab samples 15 (24.2%). Ten 
isolates (16.1%) were from urine samples and 6 
samples (9.7%) were isolated from ETA samples. 
ESBL production was found in 43/86 of the total 
isolates (50 %). The frequencies of ESBL genes 
varied among isolates with 28, 5 and 4 isolates 
being positive for blaSHV, blaTEMand blaCTX-M genes 
respectively. Two of these isolates contained dual 
resistance determinants for blaSHV and blaCTX-M. 
Class C (AmpC) b - lactamases were detected in 19 
(22.1%) isolates. Molecular genetic basis for AmpC 
production determinants were as follows: 9, 7 and 
1 isolates producing blaCMY-2, blaDHA and blaACC, 
respectively. 
Two isolates contained both blaCMY-2 and blaTEM, 
one isolate had both blaTEM and blaDHA resistance 
genes, one more isolate possessed blaSHV and 
blaACC. Two isolates possessed triple resistance 
genes (blaCMY-2, blaSHV, and blaCTX-M) (Table 3). The 
(9) K. pneumoniae isolates carrying isolated blaCMY-2 
plasmid were used as donors for both transformation 
and conjugation experiments. Transmissibility of 
antibiotic resistance plasmid blaCMY-2 was 100% 
successful by transformation to the competent E. 
coli LE392. Conjugation experiment was (77.8%) 
successful, 7 of the 9 K. pneumoniae isolates which 
were selected as donors. 
Table 2.  Distribution of 62 phenotypically 
detected beta-lactamase producing 
K. pneumoniae from different clinical 
samples.
Sample 
site
K. pneumonia 
isolates
No. (%)lactamases 
producing 
K. pneumoniae isolates 
No. %
ESBL AmpC
Blood 31 50 26    5
Wound 15 24.2 09 6
Urine 10 16.1 05 5
ETA 06 9.7 03 3
Total 62 100 43 (69.4)* 19 (30.6)
*Represent 50% of the total K. pneumoniae isolates
Table 3.  Distribution of gene resistance 
determinants in the 54 beta lactamase 
producing K. pneumoniae
Molecular resistance determinants 
of Beta lactamase No. (%)
 1. blaSHV 28 (51.9%)
 2. blaTEM 5 (9.2%)
 3. blaCTX- M  4 (7.4%)
 4. blaCMY-2 9 (16.7)
 5. blaDHA 7 (13%)
 6. blaACC 1 (1.9%)
 7. blaSHV + blaCTX-M 2*
 8. blaTEM + blaCMY-2 2*
 9. blaTEM + blaDHA 1*
10. blaSHV + blaACC 1*
11. blaCMY-2 + blaSHV + bla CTX- M 2*
*Combined genes were already calculated among the individual 
genes in cells 1-6 
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Discussion
Klebsiella pneumoniae has a feature of being 
one of the most common species harboring 
beta lactamases. Extensive use of antibiotics has 
contributed greatly to the emergence of multidrug 
resistant Klebsiella strains that cause hospital 
infections (18).
This study indicated that K. pneumoniae was 
responsible for 12.6% of nosocomial infection and 
(50%) of those isolates were ESBL produces. Higher 
ESBL production of K. pneumoniae clinical isolates 
(67%) was also reported by Abdel-Hady et al.(19) 
in Egyptian neonates hospitalized in ICU. However, 
a much lower incidence (2.97%) was reported by 
Romero et al.(20) in Spanish patients and healthy 
person. Therefore, wide range of incidence of 
ESBL production among organisms including K. 
pneumoniae can be attributed to the source of 
isolates, different antibiotic policies, empirical 
treatment and the age of patients enrolled in 
different studies. A study in an Egyptian University 
Hospital in 2010 reported the ESBL production 
rate of 76.5% in K. pneumoniae (21). The high 
rate of ESBL producers among clinical isolates in 
the developing world is troublesome due to lack 
of financial support for effective infection control 
and limited sources of effective antimicrobials. 
These factors have a clear impact on the morbidity 
and mortality related to infections caused by ESBL 
producers
This study demonstrated that blaSHV was the 
most common resistance determinant accounting 
for 51.9% of the K. pneumoniae isolates, followed 
by blaCMY, blaDHA, blaTEM and blaCTX-M at rates 
of 16.7%, 13 %, 9.2% and 7.4% , respectively, 
These findings are lower than the results reported 
by Guiqing Wang and co-workers in USA (22) who 
detected blaSHV and blaTEM genes at rates of 84.3% 
and 50.4%, respectively In contrast, the study of 
Parveen et al.( 2011) in India, reported blaCTX-M as 
the most common ESBL-type among K. pneumonia 
isolates from blood, and 92% of their strains were 
ESBLs-producers, including high rates prevalence of 
blaTEM (82%) and blaSHV 46% (23).
The present study showed that the occurrence 
rate of class C beta lactamases (Amp C) is (30.6. 
%) among our Klebsiella isolates, and this figure is 
much higher than reports from other countries like 
Korea (3.1%) (24) and the United States (1.2%) 
(25). Additionally, our result was also less than those 
reported recently from Cairo (34.8%) and Korea 
(39.3%), respectively (26, 27). While this study 
demonstrated that blaCMY-2 is the most prevalent 
gene (51.9%), followed by blaDHA (13.2%). The 
study of Al-Agamy (28) in Egypt, reported less 
prevalence rate of blaCMY-2 (5%) and slightly more rate 
of blaDHA (23.5%). Furthermore, a second Egyptian 
study by the same author demonstrated blaCMY, as 
a sole gene among AmpCß- lactamase genes in the 
Klebsiella isolates (29), whereas a Turkish study has 
found that all their K. pneumoniae isolates carried 
MOX group genes but blaDHA and blaACC genes 
were not detected (30). All these results confirm 
the fact that these ESBL types are widely different 
within the same and each country. 
In conclusion, this study demonstrates that the 
majority of Klebsiella isolates are multidrug resistant 
and producers of beta lactamases. The potential 
of these isolates in horizontal spread of resistance 
genes represent a real risk for failure of therapy by 
third generation cephalosporins. 
This article is available from: www.iajaa.org   /   www.medbrary.com
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